A national medicines regulatory authority is updating its re…
A national medicines regulatory authority is updating its regulatory framework in accordance with WHO TRS 1033 Annex 11: Good regulatory practices in the regulation of medical products. The revised system introduces documented procedures, conflict-of-interest controls, public communication procedures, and standardised scientific review processes. Which option best reflects the core principles of Good Regulatory Practice described in WHO TRS 1033 Annex 11?